Proust C, Trignol-Viguier N, Marret H
Pôle de gynécologie obstétrique, centre hospitalo-universitaire de Tours, hôpital Bretonneau, 2, boulevard Tonnellé, 37044 Tours cedex 1, France.
Pôle de gynécologie obstétrique, centre hospitalo-universitaire de Tours, hôpital Bretonneau, 2, boulevard Tonnellé, 37044 Tours cedex 1, France.
Gynecol Obstet Fertil Senol. 2022 Jul-Aug;50(7-8):527-534. doi: 10.1016/j.gofs.2022.02.077. Epub 2022 Feb 26.
To date, oral contraceptives remain the most frequently prescribed contraceptive method. New combined oral contraceptive (COC) regimens (continued, extended or flexible) were developed to try and space out or avoid withdrawal bleedings in order to meet women's expectations and improve their quality of life. However, there is no recommendation published regarding the management of the prescription. The purpose of our study was to describe provider's prescription habits when it comes to new COC regimens.
This is a descriptive observational study. A questionnaire was sent to gynecologists, general practitioners and midwives employed or in training in the Centre Valde Loire region. Prescription habits and knowledge about new oral contraceptive regimens were evaluated.
83% of health professionals frequently prescribed new COC regimens. Most frequent indications were endometriosis, severe menstruation-associated symptoms, patient's desire for amenorrhea or patient's request. The extended regimen (hormone-free interval not every month) was the most frequently used. Provider's knowledge about indications and benefits of those new regimens were satisfactory. However, scientific societies guidelines were poorly acquired.
New COC regimens are frequently proposed by health care professionals with large variability in terms of prescription model. Along with reinforcement of COC prescription guidelines for healthcare professionals, further researches are needed to better understand differences in tolerability and acceptability in terms of quality of life of the several potential regimens.
迄今为止，口服避孕药仍然是最常被处方的避孕方法。新的复方口服避孕药（COC）方案（持续、延长或灵活方案）被开发出来，试图拉开或避免撤退性出血，以满足女性的期望并改善她们的生活质量。然而，关于这些方案的处方管理尚无相关建议发布。我们研究的目的是描述医疗服务提供者在新COC方案方面的处方习惯。
这是一项描述性观察研究。向卢瓦尔河谷地区受雇或正在接受培训的妇科医生、全科医生和助产士发送了一份问卷。评估了他们的处方习惯以及对新口服避孕药方案的了解情况。
83%的医疗专业人员经常开具新的COC方案处方。最常见的适应证是子宫内膜异位症、与月经相关的严重症状、患者对闭经的需求或患者的要求。延长方案（无激素间隔不是每月一次）是最常用的。医疗服务提供者对这些新方案的适应证和益处的了解情况令人满意，但对科学协会的指南了解不足。
医疗保健专业人员经常推荐新的COC方案，在处方模式方面存在很大差异。除了加强针对医疗保健专业人员的COC处方指南外，还需要进一步研究，以更好地了解几种潜在方案在生活质量方面的耐受性和可接受性差异。
